维力医疗收盘上涨2.83%，滚动市盈率18.62倍，总市值43.64亿元

Core Viewpoint - Vili Medical's stock closed at 14.9 yuan, up 2.83%, with a rolling PE ratio of 18.62, marking a new low in 410 days, and a total market value of 4.364 billion yuan [1] Company Summary - Vili Medical specializes in the research, production, and sales of medical catheters in fields such as anesthesia, urology, respiratory care, and hemodialysis [1] - The company's main products include tracheal intubation, laryngeal masks, bronchial intubation, visual bronchial intubation, tracheostomy tubes, anesthesia masks, artificial noses, anesthesia breathing circuits, electronic analgesia pumps, urinary catheters, urinary bags, antibacterial urinary catheters, temperature-measuring urinary catheters, drainage bags, male urinary catheters, precision urinary bags, minimally invasive dilation drainage kits, guidewires, balloon dilation catheters, ureteral dilators, ureteral guiding sheaths, stone retrieval baskets, ureteral stents, and ureteral catheters [1] Financial Performance - For the first half of 2025, Vili Medical reported operating revenue of 745 million yuan, a year-on-year increase of 10.19%, and a net profit of 121 million yuan, up 14.17%, with a gross profit margin of 45.04% [1] Industry Summary - The average PE ratio for the medical device industry is 56.56, with a median of 39.76, placing Vili Medical at 40th in the industry ranking [1] - The industry average PE (TTM) is significantly higher than Vili Medical's current PE of 18.62, indicating potential undervaluation [2]